Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
| Brand name | SUCCINYLCHOLINE CHLORIDE |
| Generic name | SUCCINYLCHOLINE CHLORIDE |
| Active ingredient(s) | SUCCINYLCHOLINE CHLORIDE |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 70710-1377-1 |
| Full product label | Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton). |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | MS, OH, LA, and Puerto Rico |
| Quantity | 270,125 Vials |
| Recall initiated | 2025-08-27 |
| Report date | 2025-09-17 |
| Recall completed | — |
| Recall number | D-0623-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗